Total Holdings
66
Portfolio diversification across 66 positions
BBP
(NYSEARCA)Virtus LifeSci Biotech Products ETF
$82.16-- (--)
Loading... - Market loading
BBP ETF Holdings: Virtus LifeSci Biotech Products ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$45.52M
Total fund assets
Expense Ratio
0.79%
Annual management fee
Fund Issuer
Virtus Investment Partners
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | ImmunityBio, Inc. | Stock | 3.75% |
| 2 |  | Travere Therapeutics Inc | Stock | 3.32% |
| 3 |  | Ionis Pharmaceuticals, Inc | Stock | 3.14% |
| 4 |  | Insmed Incorporated | Stock | 2.85% |
| 5 |  | Tarsus Pharmaceuticals Inc | Stock | 2.82% |
| 6 |  | Madrigal Pharmaceuticals, Inc | Stock | 2.72% |
| 7 |  | BridgeBio Pharma, Inc | Stock | 2.64% |
| 8 |  | Rhythm Pharmaceuticals, Inc | Stock | 2.64% |
| 9 |  | Roivant Sciences Ltd | Stock | 2.63% |
| 10 |  | Krystal Biotech, Inc | Stock | 2.49% |
| 11 |  | United Therapeutics Corporation | Stock | 2.42% |
| 12 |  | Mirum Pharmaceuticals, Inc. | Stock | 2.37% |
| 13 |  | Theravance Biopharma Inc | Stock | 2.36% |
| 14 |  | Amicus Therapeutics, Inc | Stock | 2.27% |
| 15 |  | Ligand Pharmaceuticals Incorporated | Stock | 2.26% |
| 16 |  | Dynavax Technologies Corporation | Stock | 2.25% |
| 17 |  | Ardelyx, Inc | Stock | 2.24% |
| 18 |  | Moderna, Inc. | Stock | 2.18% |
| 19 |  | PTC Therapeutics, Inc | Stock | 2.09% |
| 20 |  | Phathom Pharmaceuticals, Inc | Stock | 2.05% |
| 21 |  | Regeneron Pharmaceuticals, Inc | Stock | 2.03% |
| 22 |  | CRISPR Therapeutics AG | Stock | 1.99% |
| 23 |  | Axsome Therapeutics, Inc | Stock | 1.98% |
| 24 |  | Halozyme Therapeutics, Inc. | Stock | 1.98% |
| 25 |  | Day One Biopharmaceuticals, Inc. | Stock | 1.97% |
| 26 |  | Incyte Corporation | Stock | 1.96% |
| 27 |  | Gilead Sciences, Inc. | Stock | 1.95% |
| 28 |  | Alnylam Pharmaceuticals, Inc | Stock | 1.92% |
| 29 |  | Novavax, Inc. | Stock | 1.88% |
| 30 |  | Biogen Inc | Stock | 1.84% |
| 31 |  | Apellis Pharmaceuticals, Inc | Stock | 1.83% |
| 32 |  | Amgen Inc. | Stock | 1.82% |
| 33 |  | Neurocrine Biosciences, Inc | Stock | 1.75% |
| 34 |  | BioNTech SE | Stock | 1.75% |
| 35 |  | Ascendis Pharma AS | Stock | 1.74% |
| 36 |  | ACADIA Pharmaceuticals Inc | Stock | 1.74% |
| 37 |  | BeOne Medicines AG | Stock | 1.71% |
| 38 |  | Geron Corporation | Stock | 1.69% |
| 39 |  | Iovance Biotherapeutics, Inc. | Stock | 1.69% |
| 40 |  | Harmony Biosciences Holdings Inc | Stock | 1.68% |
| 41 |  | BioMarin Pharmaceutical Inc. | Stock | 1.68% |
| 42 | B BGNE | BeiGene, Ltd | Stock | 1.64% |
| 43 |  | Exelixis, Inc. | Stock | 1.63% |
| 44 |  | Kiniksa Pharmaceuticals International, plc | Stock | 1.61% |
| 45 |  | Immunocore Holdings plc | Stock | 1.42% |
| 46 |  | Vertex Pharmaceuticals Incorporated | Stock | 1.37% |
| 47 |  | ADMA Biologics, Inc | Stock | 1.33% |
| 48 |  | Ultragenyx Pharmaceutical Inc | Stock | 1.30% |
| 49 |  | TG Therapeutics, Inc | Stock | 1.21% |
| 50 |  | Agios Pharmaceuticals, Inc | Stock | 1.13% |